Blood test results and information taken during the clinical trial will be kept strictly confidential.
Read more →At the start of the trial we will ask for your permission for us to inform your GP that you are taking part in the trial. We will send your GP an information sheet giving details of the trial and what taking part will involve for you.
Read more →If your treatment device stops working then please contact your local trial team. If necessary, your local trial team will contact an Airsonett® engineer to repair the device.
Read more →Prior to delivery of the device you will be given a ‘footprint’ template of the treatment device to see whether it will be possible to install the device in your bedroom. In a previous study including over 300 patients, there were only 2 cases where the device
Read more →The device will be installed in your home by a trained engineer. Delivery will be arranged at a convenient time within 10 days of your second visit with the trial team (the baseline visit.) The device will be installed in your bedroom and you will be shown
Read more →The LASER trial is a randomised, placebo-controlled trial. This means that we will be comparing the effect of 12 months of treatment with an active treatment device with 12 months of treatment with a placebo device. We will recruit 222 patients to the trial. Half (111) will
Read more →There are no known side effects directly attributable to the Airsonett® treatment device or Temperature-controlled Laminar Airflow treatment, a non-invasive, non-pharmaceutical treatment.
Read more →Airsonett® is a CE marked medical device and is licensed within the UK for its use in the treatment of allergic asthma.
Read more →